Disease/Infection News

RSS

Tests show Haitian cholera strains match ones from South Asia, CDC says

Tests have shown that the strain in Haiti's cholera outbreak is similar to cholera strains found in South Asia, the CDC said on Monday, Agence France-Presse reports (11/1).

3 Nov 2010

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

GenMark Diagnostics, Inc. a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States.

3 Nov 2010

Patients with advanced oropharyngeal cancer caused by HPV have better chances of survival

When the human papillomavirus (HPV) is found in cancer tumours of the tonsil and base of the tongue, patients are more likely to survive following treatment.

3 Nov 2010

Study shows Lactobacillus reuteri bacteria promotes health

There is a great deal of interest in the impact of lactic acid bacteria on our health. Now a new study from the Faculty of Health and Society, Malmö University, in Sweden, shows that the occurrence of Lactobacillus reuteri in the body promotes health.

3 Nov 2010

Inviragen receives two grants to develop dengue and chikungunya vaccines

Inviragen, a biotechnology company developing vaccines to protect against infectious diseases worldwide, announced today that it has received two grants totaling $488,958 through the United States government's Qualifying Therapeutic Discovery Project Program.

3 Nov 2010

Combining telaprevir regimen with standard therapy improves SVR rate in hepatitis C

For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.

3 Nov 2010

Virus fighting just got a new boost

In a ground breaking study in the UK researchers have identified a previously unknown mechanism that allows the immune system to fight viruses even after they have infected cells. Until now it was believed that antibodies can act only before the virus enters the cells. The team now has found that antibodies that attached themselves to a virus were able to follow it into cells and help to destroy the virus before it started to reproduce. This could open up new avenues of therapy.

2 Nov 2010

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has entered into a Cooperative Research and Development Agreement ("CRADA") with The Walter Reed Army Institute of Research.

2 Nov 2010

Inhibitex to present INX-189 data for HCV infections at AASLD Meeting

Inhibitex, Inc. announced today that three posters describing preclinical data on INX-189, the Company's nucleotide polymerase inhibitor in clinical development for the treatment of chronic hepatitis C (HCV) infections, will be presented by various scientists from the Company at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA.

2 Nov 2010

VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011

VaxInnate Corporation announced today that VAX125, its investigational prototype vaccine for seasonal flu, has been named one of the Top 10 Infectious Diseases Projects to Watch in 2011 by Elsevier Business Intelligence and the Windhover Conferences.

2 Nov 2010

Vacuum cleaner with UV technology effective at reducing carpet's surface microbes

New research suggests that the addition of ultraviolet light to the brushing and suction of a vacuum cleaner can almost double the removal of potentially infectious microorganisms from a carpet's surface when compared to vacuuming alone.

2 Nov 2010

ADVANCE Phase 3 study confirms clinical benefits of telaprevir regimen in patients with HCV infection

The Phase 3 results from the ADVANCE study confirm the clinical benefits of telaprevir-based combination therapy regimens. The study reports an improvement in treatment discontinuation rates due to adverse events compared to Phase 2 studies, and demonstrates an increase in sustained viral response (SVR) in patients with hepatitis C virus (HCV). The primary endpoint for this study was SVR 24 weeks after last treatment.

2 Nov 2010

Boceprevir combinational therapy improves SVR rate in patients with HCV genotype 1

The final results of the RESPOND-2 trial demonstrated that combination therapy with Boceprevir yields higher sustained virologic response (SVR) rates for patients with hepatitis C virus (HCV) genotype 1 who did not respond to or relapsed after treatment with peginterferon alpha 2b and Ribavirin.

2 Nov 2010

PPACA program provides $733,438 grant to Inovio

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a $733,438 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA).

2 Nov 2010

Kenya first of four countries to launch UNICEF, partners initiative aimed at PMTCT of HIV

On Friday, UNICEF and the Kenyan government announced a partnership aimed at preventing mother-to-child transmission (PMTCT) of HIV by providing HIV-positive mothers with packs of medicines they can easily administer to themselves or their babies at home, IRIN/PlusNews reports.

2 Nov 2010

AGD encourages diabetic patients to pay attention to oral health

According to the U.S. Centers for Disease Control and Prevention, diabetes affects nearly 24 million people in the United States. In observance of National Diabetes Month, the Academy of General Dentistry (AGD) encourages those with diabetes to pay extra attention to their oral health.

2 Nov 2010

WHO Director-General in Pakistan to monitor flood relief, polio vaccinations

The WHO will continue to support efforts to boost polio eradication efforts in Pakistan, WHO Director-General Margaret Chan said recently during talks with Pakistani health officials, the Associated Press of Pakistan reports.

2 Nov 2010

White House Health Advisor Emanuel visits U.S. government-funded health programs during 3-nation African trip

The global fight against malaria could cut prevalence rates of malaria to one in 20 fevers by 2017, Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said in an interview in Dakar, Senegal, Bloomberg reports.

2 Nov 2010

IRIN examines debate over malaria control versus eradication

After the recent publication of the Lancet series on malaria eradication, IRIN examines the debate over control versus eradication, stating the findings of some of the studies.

2 Nov 2010

H. pylori infection reduces severity of Salmonella-induced colitis: Research

Helicobacter pylori, a common stomach bacterium, reduced the severity of inflammation of the colon caused by Salmonella in mice, according to research from U-M Medical School scientists.

2 Nov 2010

Disease/Infection News

Tests show Haitian cholera strains match ones from South Asia, CDC says

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

Patients with advanced oropharyngeal cancer caused by HPV have better chances of survival

Study shows Lactobacillus reuteri bacteria promotes health

Inviragen receives two grants to develop dengue and chikungunya vaccines

Combining telaprevir regimen with standard therapy improves SVR rate in hepatitis C

Virus fighting just got a new boost

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

Inhibitex to present INX-189 data for HCV infections at AASLD Meeting

VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011

Vacuum cleaner with UV technology effective at reducing carpet's surface microbes

ADVANCE Phase 3 study confirms clinical benefits of telaprevir regimen in patients with HCV infection

Boceprevir combinational therapy improves SVR rate in patients with HCV genotype 1

PPACA program provides $733,438 grant to Inovio

Kenya first of four countries to launch UNICEF, partners initiative aimed at PMTCT of HIV

AGD encourages diabetic patients to pay attention to oral health

WHO Director-General in Pakistan to monitor flood relief, polio vaccinations

White House Health Advisor Emanuel visits U.S. government-funded health programs during 3-nation African trip

IRIN examines debate over malaria control versus eradication

H. pylori infection reduces severity of Salmonella-induced colitis: Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News